886762-45-4

Basic information

• Product Name: 4-(4-FLUOROPHENOXY)IODOBENZENE
• Synonyms: 4-(4-FLUOROPHENOXY)IODOBENZENE;4-Fluoro-4'-iododiphenyl ether;1-(4-Fluorophenoxy)-4-iodobenzene;1-Fluoro-4-(4-iodophenoxy)benzene
• CAS NO: 886762-45-4
• Molecular Formula: C₁₂H₈FIO
• Molecular Weight: 314.09
• Mol File: 886762-45-4.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(4-FLUOROPHENOXY)IODOBENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-FLUOROPHENOXY)IODOBENZENE(886762-45-4)
• EPA Substance Registry System: 4-(4-FLUOROPHENOXY)IODOBENZENE(886762-45-4)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 886762-45-4(Hazardous Substances Data)

Usage

General Description

4-(4-Fluorophenoxy)iodobenzene is a chemical compound with the molecular formula C12H8FIO, consisting of a benzene ring with an attached fluorophenoxy group and an iodine atom. It is primarily used as a reagent for the synthesis of organic compounds in various chemical reactions, such as Suzuki coupling reactions and carbon-carbon bond formations. 4-(4-FLUOROPHENOXY)IODOBENZENE is recognized for its ability to introduce the fluorophenoxy group and the iodine atom into organic molecules, making it a valuable building block in the synthesis of pharmaceuticals, agrochemicals, and materials science. Its unique properties and versatile applications make it an important tool for researchers and chemists in various fields.

Upstream product

• 1262991-69-4 tert-butyl 2-(4-(4’-fluorophenoxy)phenyl)azocarboxylate 
• 371-41-5 4-Fluorophenol 
• 350-46-9 4-Fluoronitrobenzene 
• 36160-82-4 4-(4-fluorophenoxy)aniline 
• 2561-25-3 4-(4-fluorophenoxy)-1-nitrobenzene 
• 1354828-66-2 tert-butyl 2-(4-cyanophenyl)diazene-1-carboxylate 
• 17672-27-4 4-hydrazinobenzonitrile 
• 92722-14-0 tert-butyl 2-(4-nitrophenyl)diazenecarboxylate 
• 92491-67-3 tert-butyl 2-(4-nitrophenyl)hydrazine-1-carboxylate 
• 352-34-1 4-fluoro-1-iodobenzene 

Downstream Products

• 1355052-34-4 2-(4-(4-fluorophenoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 1355052-14-0 (S)-N-(1,6-diamino-1-oxohexan-2-yl)-6-(4-(4-fluorophenoxy)phenyl)picolinamide 
• 1355052-62-8 methyl 4-chloro-6-(4-(4-fluorophenoxy)phenyl)picolinate 
• 1355052-63-9 methyl 6-(4-(4-fluorophenoxy)phenyl)-4-vinylpicolinate 
• 1355052-64-0 (S)-methyl 4-(1,2-dihydroxyethyl)-6-(4-(4-fluorophenoxy)phenyl)picolinate 
• 1355052-65-1 (S)-4-(1,2-dihydroxyethyl)-6-(4-(4-fluorophenoxy)phenyl)picolinic acid 
• 1355052-24-2 N-((S)-1-amino-4-methyl-1-oxopentan-2-yl)-4-((S)-1,2-dihydroxyethyl)-6-(4-(4-fluorophenoxy)phenyl)picolinamide 
• 1355052-26-4 (S)-2-(4-((S)-1,2-dihydroxyethyl)-6-(4-(4-fluorophenoxy)phenyl)picolinamido)succinamide 
• 1355052-35-5 methyl 6-(4-(4-fluorophenoxy)phenyl)picolinate 
• 361436-85-3 6-(4-(4-fluorophenoxy)phenyl)picolinic acid 
• 1355052-37-7 (6-(4-(4-fluorophenoxy)phenyl)pyridin-2-yl)(piperazin-1-yl)methanone trifluoroacetate 
• 1355051-58-9 (6-(4-(4-fluorophenoxy)phenyl)pyridin-2-yl)(4-((4-(trifluoromethoxy)phenyl)sulfonyl)piperazin-1-yl)methanone 
• 1355052-39-9 C₂HF₃O₂*C₂₀H₁₈FN₃O₂ 
• 1355051-89-6 6-(4-(4-fluorophenoxy)phenyl)-N-(2-(methylsulfonamido)ethyl)picolinamide 

Relevant articles and documents

Synthesis and Structure-Activity Relationships for Extended Side Chain Analogues of the Antitubercular Drug (6 S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5 H -imidazo[2,1- b ][1,3]oxazine (PA-824)

Novel extended side chain nitroimidazooxazine analogues featuring diverse linker groups between two aryl rings were studied as a potential strategy to improve solubility and oral activity against chronic infection by Mycobacterium tuberculosis. Both lipop

HETEROARYL COMPOUNDS AS SODIUM CHANNEL BLOCKERS

The invention relates to aryl substituted compounds of Formula (I) : and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein Het, G, A, R, and n are defined as set forth in the specification. The invention is also directed to the use

PYRIDINE COMPOUNDS AS SODIUM CHANNEL BLOCKERS

The invention relates to substituted pyridine compounds of Formula I: (I) or a pharmaceutically acceptable salt, prodrug, or solvate thereof, wherein A1, X, A2, R1a, R1b, R1c, G, and z are defined as